Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion type Assertion NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_head.
- NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion description "[When the effectiveness of glucose itself on glucose uptake and production [(Rd(hyperglycemia) - Rd(euglycemia))/deltaPG and (HGP(euglycemia)- HGP(hyperglycemia))/deltaPG] was calculated, the relatives had a 22% increase in peripheral uptake (0.022 +/- 0.002 vs. 0.018 +/- 0.002 mg x min(-1) x kg(-1) FFM per mg/dl), due to a significantly increased nonoxidative glucose metabolism and enhanced suppression of HGP (0.0076 +/- 0.0021 vs. 0.0011 +/- 0.0022 mg x min(-1) x kg(-1) FFM per mg/dl, P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_provenance.
- NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion evidence source_evidence_literature NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_provenance.
- NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion SIO_000772 10909980 NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_provenance.
- NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion wasDerivedFrom befree-2016 NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_provenance.
- NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_assertion wasGeneratedBy ECO_0000203 NP289858.RAVyolAVS3B5pOrLCUNZm72hE6nd1K-vGUrmFJhlDE04E130_provenance.